Document is current
Any future updates will be listed below
-
Authors
Sanchez-Delgado, Marta https://orcid.org/0000-0002-1412-9011
Frank, Maurice https://orcid.org/0000-0001-7943-2487
Šišmiš, Tomáš
Kahraman, Mustafa
Daniel-Moreno, Alberto
Mummery, Emmika
Ceiler, Jessika
Skottke, Jasmin
Bieg-Salazar, Carla
Hinkfoth, Franziska
Rudolf, Christina
Weiblen, Ronja https://orcid.org/0000-0003-2484-1229
Tikk, Kaja
Sikosek, Tobias https://orcid.org/0000-0001-9929-3525
Steinkraus, Bruno R. https://orcid.org/0000-0003-3757-1993
Horos, Rastislav
Urda, Michal
Rajakumar, Timothy https://orcid.org/0000-0002-0334-4349
-
Funding
Funding for this research was provided by:
Hummingbird Diagnostics GmbH
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 31 October 2025
First Online: 16 December 2025
Competing interests
: M.S.D., M.F., M.K., A.D.M., E.M., J.C., J.S., C.B.S., F.H., C.R., R.W., K.T., T.S., B.R.S., R.H., and T.R. are employees of Hummingbird Diagnostics and hold company stock options. M.S.D., M.F., M.K., B.R.S., R.H., and T.R. are inventors of patent applications related to Nanopore RNA modification profiling-based diagnostics submitted by Hummingbird Diagnostics. The remaining authors declare no competing interests.
: All patients and authors consented to the publication of the results.
